The prevalence of thrombophilia in patients with symptomatic peripheral vascular disease.

<h4>Background</h4> <p>The aim of this prospective study was to establish the prevalence of thrombophilia and hyperhomocysteinaemia using a comprehensive screen in patients with peripheral vascular disease.</p> <h4>Methods</h4> <p>A total of 150 patients wit...

Full description

Bibliographic Details
Main Authors: Vig, S, Chitolie, A, Bevan, D, Dormandy, J, Thompson, M, Halliday, A
Format: Journal article
Language:English
Published: Wiley 2006
_version_ 1797083563312545792
author Vig, S
Chitolie, A
Bevan, D
Dormandy, J
Thompson, M
Halliday, A
author_facet Vig, S
Chitolie, A
Bevan, D
Dormandy, J
Thompson, M
Halliday, A
author_sort Vig, S
collection OXFORD
description <h4>Background</h4> <p>The aim of this prospective study was to establish the prevalence of thrombophilia and hyperhomocysteinaemia using a comprehensive screen in patients with peripheral vascular disease.</p> <h4>Methods</h4> <p>A total of 150 patients with peripheral vascular disease (with an ankle brachial pressure index of less than 0·8) underwent thrombophilia screening (protein C and protein S, antithrombin, lupus anticoagulant, activated protein C resistance and factor V Leiden and prothrombin mutations). Fasting homocysteine assays were also performed.</p> <h4>Results</h4> <p>A thrombophilia defect was found in 41 patients (27·3 per cent). The commonest was protein S deficiency, found in 17 patients (11·3 per cent). Others included factor V Leiden mutation, found in 10 (6·7 per cent) and protein C deficiency, found in six (4·0 per cent). Lupus anticoagulant and prothrombin mutation were both found in six (4·0 per cent). One patient had an antithrombin deficiency. Only the presence of critical ischaemia was associated with a positive thrombophilia screen on single variable analysis (P=0·03). Hyperhomocysteinaemia was present in over a third of the study group (37·3 per cent): 45 defined as moderate and 11 as intermediate.</p> <h4>Conclusion</h4> <p>A quarter of patients with peripheral vascular disease had evidence of thrombophilia, and a third had hyperhomocysteinaemia.</p>
first_indexed 2024-03-07T01:43:14Z
format Journal article
id oxford-uuid:978bbddd-b301-4f7c-bc2c-2844de384b4a
institution University of Oxford
language English
last_indexed 2024-03-07T01:43:14Z
publishDate 2006
publisher Wiley
record_format dspace
spelling oxford-uuid:978bbddd-b301-4f7c-bc2c-2844de384b4a2022-03-27T00:00:34ZThe prevalence of thrombophilia in patients with symptomatic peripheral vascular disease.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:978bbddd-b301-4f7c-bc2c-2844de384b4aEnglishSymplectic Elements at OxfordWiley2006Vig, SChitolie, ABevan, DDormandy, JThompson, MHalliday, A<h4>Background</h4> <p>The aim of this prospective study was to establish the prevalence of thrombophilia and hyperhomocysteinaemia using a comprehensive screen in patients with peripheral vascular disease.</p> <h4>Methods</h4> <p>A total of 150 patients with peripheral vascular disease (with an ankle brachial pressure index of less than 0·8) underwent thrombophilia screening (protein C and protein S, antithrombin, lupus anticoagulant, activated protein C resistance and factor V Leiden and prothrombin mutations). Fasting homocysteine assays were also performed.</p> <h4>Results</h4> <p>A thrombophilia defect was found in 41 patients (27·3 per cent). The commonest was protein S deficiency, found in 17 patients (11·3 per cent). Others included factor V Leiden mutation, found in 10 (6·7 per cent) and protein C deficiency, found in six (4·0 per cent). Lupus anticoagulant and prothrombin mutation were both found in six (4·0 per cent). One patient had an antithrombin deficiency. Only the presence of critical ischaemia was associated with a positive thrombophilia screen on single variable analysis (P=0·03). Hyperhomocysteinaemia was present in over a third of the study group (37·3 per cent): 45 defined as moderate and 11 as intermediate.</p> <h4>Conclusion</h4> <p>A quarter of patients with peripheral vascular disease had evidence of thrombophilia, and a third had hyperhomocysteinaemia.</p>
spellingShingle Vig, S
Chitolie, A
Bevan, D
Dormandy, J
Thompson, M
Halliday, A
The prevalence of thrombophilia in patients with symptomatic peripheral vascular disease.
title The prevalence of thrombophilia in patients with symptomatic peripheral vascular disease.
title_full The prevalence of thrombophilia in patients with symptomatic peripheral vascular disease.
title_fullStr The prevalence of thrombophilia in patients with symptomatic peripheral vascular disease.
title_full_unstemmed The prevalence of thrombophilia in patients with symptomatic peripheral vascular disease.
title_short The prevalence of thrombophilia in patients with symptomatic peripheral vascular disease.
title_sort prevalence of thrombophilia in patients with symptomatic peripheral vascular disease
work_keys_str_mv AT vigs theprevalenceofthrombophiliainpatientswithsymptomaticperipheralvasculardisease
AT chitoliea theprevalenceofthrombophiliainpatientswithsymptomaticperipheralvasculardisease
AT bevand theprevalenceofthrombophiliainpatientswithsymptomaticperipheralvasculardisease
AT dormandyj theprevalenceofthrombophiliainpatientswithsymptomaticperipheralvasculardisease
AT thompsonm theprevalenceofthrombophiliainpatientswithsymptomaticperipheralvasculardisease
AT hallidaya theprevalenceofthrombophiliainpatientswithsymptomaticperipheralvasculardisease
AT vigs prevalenceofthrombophiliainpatientswithsymptomaticperipheralvasculardisease
AT chitoliea prevalenceofthrombophiliainpatientswithsymptomaticperipheralvasculardisease
AT bevand prevalenceofthrombophiliainpatientswithsymptomaticperipheralvasculardisease
AT dormandyj prevalenceofthrombophiliainpatientswithsymptomaticperipheralvasculardisease
AT thompsonm prevalenceofthrombophiliainpatientswithsymptomaticperipheralvasculardisease
AT hallidaya prevalenceofthrombophiliainpatientswithsymptomaticperipheralvasculardisease